India reported 4,270 covid cases bringing the Covid tally to 4,31,76,817. The daily positivity rate also saw a rise of more than 1 per cent after 34 days, as per the data released by the Union Health Ministry on Sunday. While the active cases increased by 1,636 cases in 24 hours.&nbsp;

According to the ministry, the daily positivity rate was 1.03 per cent and the weekly positivity rate was 0.84 per cent. .&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/india-news/corbevax-becomes-first-vaccine-in-india-to-get-dcgi-approval-for-heterologous-covid-19-booster-shot-485081">Corbevax becomes first vaccine in India to get DCGI approval for heterologous COVID-19 booster shot</a>

The data updated by the ministry on Sunday (June 5), the number of active cases increased to 24,052 cases and 15 new fatalities were reported, increasing the death toll to 5,24,692.

The 15 new fatalities include 13 from Kerala and one each from central Madhya Pradesh and western Maharashtra states.&nbsp;

So far, the country has reported 5,24,692 deaths with 1,47,865 in Maharashtra, 69,786 in Kerala, 40,107 in Karnataka, 26,212 in Delhi, 23,520 in Uttar Pradesh, 38,025 in Tamil Nadu and 21,204 in West Bengal.&nbsp;

Watch |&nbsp;Mumbai: How covid-19 changed lives of Dabbawalas

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/mumbai-how-covid-19-changed-lives-of-dabbawalas-483044/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

The total number of persons who have recovered from the virus has increased to 4,26,28,073 with 1.22 per cent fatality rate.&nbsp;

The total number of doses given in the country as part of the Covid vaccination programme has surpassed 19.4 billion&nbsp;

Also read |&nbsp;<a href="https://www.wionews.com/india-news/covid-19-indian-govt-suspects-possibility-of-localised-spread-of-infection-writes-to-five-states-484937">Covid-19: Indian govt suspects possibility of localised spread of infection, writes to five States&nbsp;</a>

Comorbidities were responsible for more than 70 per cent of the death, as per the government.

The Union Health Ministry on its official website said, “Our figures are being reconciled with the Indian Council of Medical Research.” It further added that the data is being verified and reconciled state wise.

(With inputs from agencies)

India reported 4,270 covid cases bringing the Covid tally to 4,31,76,817. The daily positivity rate also saw a rise of more than 1 per cent after 34 days, as per the data released by the Union Health Ministry on Sunday.

India reported 4,270 covid cases bringing the Covid tally to 4,31,76,817. The daily positivity rate also saw a rise of more than 1 per cent after 34 days, as per the data released by the Union Health Ministry on Sunday. While the active cases increased by 1,636 cases in 24 hours. According to the ministry, the daily positivity rate was 1.03 per cent and the weekly positivity rate was 0.84 per cent. . Also read | Corbevax becomes first vaccine in India to get DCGI approval for heterologous COVID-19 booster shot The data updated by the ministry on Sunday (June 5), the number of active cases increased to 24,052 cases and 15 new fatalities were reported, increasing the death toll to 5,24,692. The 15 new fatalities include 13 from Kerala and one each from central Madhya Pradesh and western Maharashtra states. So far, the country has reported 5,24,692 deaths with 1,47,865 in Maharashtra, 69,786 in Kerala, 40,107 in Karnataka, 26,212 in Delhi, 23,520 in Uttar Pradesh, 38,025 in Tamil Nadu and 21,204 in West Bengal. Watch | Mumbai: How covid-19 changed lives of Dabbawalas The total number of persons who have recovered from the virus has increased to 4,26,28,073 with 1.22 per cent fatality rate. The total number of doses given in the country as part of the Covid vaccination programme has surpassed 19.4 billion Also read | Covid-19: Indian govt suspects possibility of localised spread of infection, writes to five States Comorbidities were responsible for more than 70 per cent of the death, as per the government. The Union Health Ministry on its official website said, “Our figures are being reconciled with the Indian Council of Medical Research.” It further added that the data is being verified and reconciled state wise. (With inputs from agencies)

COVID-19: India reports 4,270 new cases, daily positivity rate more than 1% after a month

US State Department spokesperson Ned Price has said that United States is "very closely" tracking the course of the COVID-19 outbreak in India.

"There are protocols in place, requiring testing for international travel. What is true is that we are tracking the course of the COVID outbreak in India very closely as I mentioned before, Secretary Blinken and Foreign Minister Jaishankar did discuss it yesterday," Price said in a statement on Tuesday.

"We are committed to doing what we can both at the present. And going forward, to see to it that this virus is brought under control and I spoke again of our engagement with the who are funding to COVAX, the Quad arrangement that of course implicates. What we're seeing in India," he added.

On the COVID-19 vaccine, Price said, "Our priority is ensuring the distribution of a safe and effective vaccine to millions of Americans to all Americans who can take advantage of it. But we also know that we need to continue to demonstrate that leadership."

"When it comes to countries beyond our borders and that's precisely what we've done, as I mentioned before, we've re-engaged. The who we've committed USD 2 billion to Kovacs another USD 2 billion over time, we've spoken to our partnership with Canada and Mexico," he added.

Yesterday, The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption.

President Joe Biden and his predecessor Donald Trump had invoked the war-time Defence Production Act (DPA) that leaves US companies with no option but to give priority to the production of COVID-19 vaccines and Personal Protective Equipment (PPEs) for domestic production to combat the deadly pandemic in America, the worst-hit nation.

Since the US has ramped up the production of COVID-19 vaccines mostly by Pfizer and Moderna to meet the goal of vaccinating its entire population by July 4, the suppliers of its raw material, which is in high demand globally and sought after by major Indian manufacturers, are being forced to provide it only for domestic manufacturers.

(With inputs from agencies)

US State Department spokesperson Ned Price has said that United States is "very closely" tracking the course of the COVID-19 outbreak in India. "There are protocols in place, requiring testing for international travel.

US State Department spokesperson Ned Price has said that United States is "very closely" tracking the course of the COVID-19 outbreak in India. "There are protocols in place, requiring testing for international travel. What is true is that we are tracking the course of the COVID outbreak in India very closely as I mentioned before, Secretary Blinken and Foreign Minister Jaishankar did discuss it yesterday," Price said in a statement on Tuesday. "We are committed to doing what we can both at the present. And going forward, to see to it that this virus is brought under control and I spoke again of our engagement with the who are funding to COVAX, the Quad arrangement that of course implicates. What we're seeing in India," he added. On the COVID-19 vaccine, Price said, "Our priority is ensuring the distribution of a safe and effective vaccine to millions of Americans to all Americans who can take advantage of it. But we also know that we need to continue to demonstrate that leadership." "When it comes to countries beyond our borders and that's precisely what we've done, as I mentioned before, we've re-engaged. The who we've committed USD 2 billion to Kovacs another USD 2 billion over time, we've spoken to our partnership with Canada and Mexico," he added. Yesterday, The Biden administration has conveyed to New Delhi that it understands India's pharmaceutical requirements and promised to give the matter due consideration, observing that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption. President Joe Biden and his predecessor Donald Trump had invoked the war-time Defence Production Act (DPA) that leaves US companies with no option but to give priority to the production of COVID-19 vaccines and Personal Protective Equipment (PPEs) for domestic production to combat the deadly pandemic in America, the worst-hit nation. Since the US has ramped up the production of COVID-19 vaccines mostly by Pfizer and Moderna to meet the goal of vaccinating its entire population by July 4, the suppliers of its raw material, which is in high demand globally and sought after by major Indian manufacturers, are being forced to provide it only for domestic manufacturers. (With inputs from agencies)

We are tracking the course of the COVID outbreak in India very closely: US

covid-outbreak-in-india

Covid Outbreak In India, News on Covid Outbreak In India, stories on Covid Outbreak In India, articles on Covid Outbreak In India, Covid Outbreak In India stories at Wion, Covid Outbreak In India news, Covid Outbreak In India latest news

covid outbreak-in-india

COVID-19: India reports 4,270 new cases, daily positivity rate more than 1% after a month

We are tracking the course of the COVID outbreak in India very closely: US